Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:November 28, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:November 28, 2022Not yet recruiting
Condition(s):PeriodontitisLast Updated:May 30, 2019Completed
Condition(s):CholangiocarcinomaLast Updated:May 21, 2013Suspended
Condition(s):Chronic PeriodontitisLast Updated:February 20, 2012Completed
Condition(s):Lung Cancer; Lung Cancer MetastaticLast Updated:February 16, 2024Recruiting
Condition(s):RetinoblastomaLast Updated:June 12, 2020Completed
Condition(s):Central Serous ChorioretinopathyLast Updated:February 16, 2015Unknown status
Condition(s):Actinic Keratosis; Photodynamic TherapyLast Updated:January 10, 2024Completed
Condition(s):CholangiocarcinomaLast Updated:June 3, 2015Terminated
Condition(s):Simvastatin; Photodynamic Therapy; Periodontal DiseasesLast Updated:September 2, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.